Nov.10 — Eli Lilly & Co. Chairman and Chjef Executive Officer David Ricks discusses the drugmaker’s Covid-19 antibody therapy bamlanivimab, which was recently granted an emergency-use authorization by the U.S. Food and Drug Administration. He…
Eli Lilly Antibody Drug Will Reduce Hospitalizations: CEO
0 Comments
Most Voted